Alembic Pharmaceuticals Limited has officially announced the appointment of Mr. Rajkumar Baheti as a Non-Executive Non-Independent Director, effective April 1, 2026. His appointment follows the recommendation of the Nomination and Remuneration Committee and subsequent approval by shareholders. Mr. Baheti brings extensive leadership experience to the company’s board, further strengthening its governance framework.
Board Appointment Overview
Effective April 1, 2026, Alembic Pharmaceuticals has inducted Mr. Rajkumar Baheti to its Board of Directors. Serving as a Non-Executive Non-Independent Director, Mr. Baheti is liable to retire by rotation. His appointment was ratified by the company’s shareholders through a postal ballot concluded on March 31, 2026.
Professional Background
Mr. Baheti is a distinguished professional with a career spanning 44 years. He is a commerce graduate and a fellow member of both the Institute of Chartered Accountants of India and the Institute of Company Secretaries of India. Throughout his career, he has held significant senior leadership positions in reputed organizations, demonstrating deep expertise in corporate finance, financial governance, and regulatory compliance.
Leadership and Governance
The company confirmed that Mr. Baheti is not related to any of the existing Directors or Key Managerial Personnel. His addition to the board is expected to contribute to the strategic oversight of the organization, leveraging his decades of complex financial experience to support the company’s long-term objectives and governance standards.
Source: BSE
